Efficacy and Safety of Fosaprepitant in Preventing Chemotherapy-induced Vomiting in Children Treated With Medium and High Emetic Chemotherapeutic Drugs

NCT05230654 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy Induced Nausea and Vomiting Pediatric Cancer Patients

Interventions

DRUG: Fosaprepitant
DRUG: Placebo(normal saline)

Sponsor

Shanghai Children's Medical Center